Source: CURATED
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
5-hydroxytryptamine receptor 2C | 0.555 | 0.692 | 3.7E-02 |
|
disease | 0.360 | None | 0.200 | 5 | 0 | 1999 | 2004 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.400 | None | 0.400 | 5 | 0 | 2004 | 2020 | ||||||||
|
gamma-aminobutyric acid type B receptor subunit 1 | 0.587 | 0.769 | 1.00 |
|
disease | 0.560 | None | 0.500 | 5 | 0 | 1999 | 2018 | ||||||||
|
cholecystokinin | 0.453 | 0.846 | 3.3E-05 |
|
disease | 0.340 | None | 0.500 | 2 | 0 | 1998 | 2005 | ||||||||
|
cadherin 12 | 0.821 | 0.308 | 3.6E-04 |
|
disease | 0.310 | None | 0.500 | 2 | 0 | 2011 | 2012 | ||||||||
|
SH3GL interacting endocytic adaptor 1 | 0.890 | 0.154 | 1.00 |
|
disease | 0.330 | None | 0.500 | 2 | 0 | 2010 | 2016 | ||||||||
|
glutamate ionotropic receptor kainate type subunit 3 | 0.674 | 0.538 | 1.00 |
|
disease | 0.320 | None | 0.500 | 2 | 0 | 2006 | 2013 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.300 | None | 0.500 | 2 | 0 | 2009 | 2010 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.340 | None | 0.500 | 2 | 0 | 2009 | 2019 | ||||||||
|
tyrosine hydroxylase | 0.462 | 0.885 | 1.7E-06 |
|
disease | 0.360 | None | 0.600 | 5 | 0 | 1994 | 2005 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit alpha6 | 0.678 | 0.423 | 1.3E-12 |
|
disease | 0.340 | None | 0.667 | 3 | 0 | 1999 | 2019 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit beta2 | 0.619 | 0.500 | 0.85 |
|
disease | 0.320 | None | 0.667 | 3 | 0 | 2005 | 2010 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.330 | None | 0.667 | 3 | 0 | 2008 | 2010 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit alpha1 | 0.563 | 0.577 | 0.91 |
|
disease | 0.340 | None | 0.667 | 3 | 0 | 2003 | 2019 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.340 | None | 0.750 | 4 | 0 | 2002 | 2008 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.330 | None | 0.750 | 4 | 0 | 2005 | 2018 | ||||||||
|
opioid receptor delta 1 | 0.604 | 0.731 | 3.3E-03 |
|
disease | 0.330 | None | 0.750 | 4 | 0 | 2007 | 2009 | ||||||||
|
5-hydroxytryptamine receptor 3A | 0.608 | 0.538 | 1.7E-10 |
|
disease | 0.340 | None | 0.750 | 4 | 0 | 2009 | 2016 | ||||||||
|
taste 2 receptor member 38 | 0.531 | 0.808 | 0.13 |
|
disease | 0.540 | None | 0.750 | 4 | 0 | 1992 | 2010 | ||||||||
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
disease | 0.600 | None | 0.800 | 7 | 0 | 1998 | 2020 | ||||||||
|
prodynorphin | 0.535 | 0.577 | 1.7E-04 |
|
disease | 0.600 | None | 0.800 | 7 | 0 | 1997 | 2018 | ||||||||
|
cholecystokinin A receptor | 0.615 | 0.500 | 4.0E-03 |
|
disease | 0.530 | None | 0.800 | 6 | 0 | 1998 | 2005 | ||||||||
|
opioid receptor mu 1 | 0.457 | 0.808 | 7.9E-11 |
|
disease | 0.600 | None | 0.800 | 6 | 0 | 1998 | 2019 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit alpha2 | 0.641 | 0.346 | 1.00 |
|
disease | 0.700 | None | 0.800 | 6 | 0 | 2004 | 2017 | ||||||||
|
ankyrin repeat and kinase domain containing 1 | 0.604 | 0.462 | 7.4E-12 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 2004 | 2017 |